REPL News and Press, Replimune Group Inc. From 08/07/25

2025-08-07 10:43:47 ET More on Replimune Group Replimune Group: The Prospects For FDA Approval After Rejection Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript Replimune down as ...

2025-08-07 10:08:04 ET Topline Summary and Update Read the full article on Seeking Alpha For further details see: Replimune Group: The Prospects For FDA Approval After Rejection

WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal first quarter ended June 30, 2025 and provided a busin...

Replimune Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL Replimune Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL...

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 17.1% to $2.46 on volume of 264,409,281 shares AtlasClear Holdings Inc. (ATCH) rose 39.5% to $0.2216 on volume of 218,466,534 shares NVIDIA Corporation (NVDA) rose 3.6% to $180 on volume of 145,593,...

A look at the top 10 most actives in the United States AtlasClear Holdings Inc. (ATCH) rose 37.7% to $0.2187 on volume of 122,410,058 shares Oriental Rise Holdings Limited (ORIS) rose 15.3% to $0.1266 on volume of 91,052,874 shares Opendoor Technologies Inc (OPEN) rose 8.5% to $2.279 on vol...

New York, New York--(Newsfile Corp. - August 4, 2025) -  If you suffered a loss on your Replimune Group, Inc. (NASDAQ: REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/repl...

2025-08-04 06:57:54 ET More on Replimune Group Replimune: A Surprise CRL Exposes Fragility Of The Melanoma Program Replimune Group, Inc. (REPL) Q4 2025 Earnings Call Transcript Replimune Group: Analysts Are More Optimistic Than The Market Replimune surges as ...

Philadelphia, Pennsylvania--(Newsfile Corp. - July 31, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Replimune Group, Inc. (NASDAQ: REPL). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. I...

A look at the top 10 most actives in the United States Healthcare Triangle Inc. (HCTI) fell 40.6% to $0.0302 on volume of 679,551,998 shares OceanPal Inc. (OP) rose 24.6% to $0.1749 on volume of 453,031,715 shares Incannex Healthcare Inc. (IXHL) fell 17.8% to $0.88 on volume of 414,920,824 ...